financetom
Business
financetom
/
Business
/
Here’s why Sourav Ganguly chose to become a Complan boy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Here’s why Sourav Ganguly chose to become a Complan boy
Jun 17, 2018 4:56 AM

KraftHeinz India recently appointed former cricketer Sourav Ganguly as a brand ambassador for their brand, Complan, that promised helping us excel in Maths while we were growing up.

Storyboard caught up with the cricketer to find out how he chooses brands and why he chose to become a Complan Boy.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Profits at Chile's Copec up nearly five fold in second quarter
Profits at Chile's Copec up nearly five fold in second quarter
Aug 14, 2024
Aug 14 (Reuters) - Chilean industrial conglomerate Empresas Copec on Wednesday posted a second-quarter net profit of $288 million, up nearly five times compared to profits of $59 million in the same quarter last year. Copec's revenues during the April-to-June period grew 3% to total $7.1 billion. ...
Cantor Equity Partners Closes $100 Million IPO
Cantor Equity Partners Closes $100 Million IPO
Aug 14, 2024
05:49 PM EDT, 08/14/2024 (MT Newswires) -- Cantor Equity Partners ( CEP ) said late Wednesday that it closed its initial public offering of 10 million Class A ordinary shares at $10 apiece. The company said its shares began trading Tuesday on the Nasdaq Global Market under the symbol CEP. ...
Update: Alaska Air Group Flight Attendants Reject Labor Accord
Update: Alaska Air Group Flight Attendants Reject Labor Accord
Aug 14, 2024
05:56 PM EDT, 08/14/2024 (MT Newswires) -- (Updates with comment from Alaska Air's ( ALK ) spokesperson in the fifth paragraph.) Alaska Air Group ( ALK ) flight attendants voted against a tentative labor agreement, the Association of Flight Attendants-CWA said Wednesday in a statement. In June, Alaska Air ( ALK ) and the association entered into a tentative agreement...
Incyte, Syndax Pharmaceuticals Get FDA Approval for Graft-Versus-Host Treatment
Incyte, Syndax Pharmaceuticals Get FDA Approval for Graft-Versus-Host Treatment
Aug 14, 2024
05:59 PM EDT, 08/14/2024 (MT Newswires) -- Incyte ( INCY ) and Syndax Pharmaceuticals ( SNDX ) said late Wednesday that the US Food and Drug Administration has approved niktimvo to treat chronic graft-versus-host disease. The treatment is for patients who have endured failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved